Insider Cluster (2 insiders) ·Filed Jun 23, 2026

KYMR

Kymera Therapeutics, Inc.
NEUTRAL
Impact 3/10
Horizondays Processed3mo ago
Insider cluster: 2 insiders, $1.6M total
Actionable Insight • Neutral

The cluster is routine in size and pattern — Booth's sales are large in absolute terms but immaterial relative to KYMR's $7.4B market cap. Goodman's sales are tied to option exercises, likely for tax or diversification purposes. No bearish signal here; monitor for any material insider buying or a larger cluster (>0.5% of market cap) to indicate a change in sentiment.

DirectionNeutral
Confidencehigh
Horizondays
Final — all horizons settled through T+60d
KYMR ▲ +18.40% at T+60d
NEUTRAL call ✓ call won +18.40% · α vs SPY +15.16% · entry $98.25 → $116.33
Entry anchored
Jun 22, 07:04 PM ET
via exchange tick
T+1d
+1.65%
call +1.65% · α +1.70%
$99.87
settled 3mo ago
T+5d
+11.27%
call +11.27% · α +10.26%
$109.32
settled 3mo ago
T+20d
+13.04%
call +13.04% · α +11.88%
$111.06
settled 2mo ago
T+60d
+18.40%
call +18.40% · α +15.16%
$116.33
settled 16d ago

Price Chart

Loading chart...

Executive Summary

Two Kymera insiders (Director Bruce Booth and CBO Noah Goodman) sold a combined $1.62M in open-market shares over a 7-day window, with Booth alone accounting for $1.37M. The sales are modest relative to KYMR's $7.4B market cap (~0.02%), and Goodman's sales are tied to derivative exercises, reducing their informational signal. The cluster is notable for involving a director and an officer, but the dollar amounts are trivial for a company of this size.

Key Financial Metrics

Direction
selling
Total Value
$1.6M
Insiders
2

Key Facts

  • Director Bruce Booth sold 14,921 shares at $92.14 on 2026-06-22, totaling $1.37M
  • CBO Noah Goodman sold 2,500 shares at $99.00 on 2026-06-22, totaling $247,500
  • Goodman's sale followed derivative exercises at $0 and $21.05 per share (non-cash and cash exercises)
  • Booth also sold 62,897 shares at $90.48 on 2026-06-18 and 11,741 shares at $89.98 on 2026-06-17
  • Total open-market sales in the cluster: ~$1.62M, representing ~0.02% of KYMR's $7.4B market cap
  • No insider purchases were reported in the cluster window

Financial Impact

Total insider sales of $1.62M, or ~0.02% of market cap — trivial relative to company size

insider ownershipdilution

Risk Factors

  • Director Booth has sold ~$8.1M total over the past 30 days, which could indicate a gradual de-risking if sustained
  • No insider buying to offset the selling pattern — a one-sided sell cluster, though small

Market Snapshot

Exchange
Nasdaq
Sector
Biological Products, (No Diagnostic Substances)
Analyst Consensus
93% bullish (30 analysts)

Investment Themes

Biotech & Drug Discovery

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CLUSTER Data (Synthetic)cluster-KYMR-1782176497036
30 reports for KYMR
Performance horizon
67% Hit rate 8 of 12 directional calls best @ T+60▲ +60.99%Jun 8, 2026
Filters
Rows
Reports for KYMR — sortable, filterable
TypeNow
Aug 5, 2026
8w ago
8-K
BULLISH ★ 6/10
$105.48 $118.63▲ +12.47%▲ +13.07%$107.39 (+1.81%)
Jul 8, 2026
12w ago
Insider Cluster
BEARISH ★ 5/10
$114.16 $105.48▲ +7.60%▲ +10.88%$107.39 (+5.93%)
Jul 2, 2026
13w ago
Insider Cluster
BEARISH ★ 6/10
$113.51 $107.01▲ +5.73%▲ +5.31%$107.39 (+5.39%)
Jul 2, 2026
13w ago
Insider Cluster
BEARISH ★ 5/10
$113.51 $107.01▲ +5.73%▲ +5.31%$107.39 (+5.39%)
Jun 30, 2026
13w ago
144
BEARISH ★ 4/10
$114.20 $105.25▲ +7.84%▲ +5.65%$107.39 (+5.96%)
Jun 29, 2026
13w ago
144
NEUTRAL ★ 4/10
$114.67 $110.05▼ −4.03%▼ −3.00%$107.39 (−6.35%)
Jun 26, 2026
13w ago
Insider Cluster
BEARISH ★ 6/10
$109.32 $110.57▼ −1.14%▼ −1.42%$107.39 (+1.77%)
Jun 26, 2026
13w ago
144
BEARISH ★ 6/10
$109.32 $110.57▼ −1.14%▼ −1.42%$107.39 (+1.77%)
Jun 26, 2026
14w ago
144
BEARISH ★ 6/10
$109.32 $110.57▼ −1.14%▼ −1.42%$107.39 (+1.77%)
Jun 24, 2026
14w ago
144
NEUTRAL ★ 2/10
$116.46 $110.38▼ −5.22%▼ −5.75%$107.39 (−7.79%)
Showing 10 of 30

US Market Status

Market Closed — Opens Mon (64h 21m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access
Report published Jun 23, 2026